Performance of neoadjuvant therapy in locally advanced adenocarcinoma of the pancreas: A single large volume center experience.
2020
e16745Background: Pancreatic adenocarcinoma (PC) is a disease with low 5-year survival rates even in patients who undergo surgical resection: ~10% overall and 20-35% in those with negative lymph no...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI